VITRAKVI 20mg/ml x 50ml (Larotrectinib Syrup) 20mg/ml x 50ml

Vitrakvi (larotrectinib) is a prescription syrup used for treating solid tumors with a specific genetic alteration. This 20mg/ml x 50ml formulation is designed for targeted therapy in eligible patients. Vitrakvi syrup is a precision oncology treatment administered under medical supervision.

Strength

20mg/ml x 50ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

BAYER (SCHWEIZ) AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vitrakvi (larotrectinib) is prescribed for adults and children with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion. It is used when the cancer has spread or cannot be surgically removed. This targeted therapy helps control tumor growth by blocking signals that drive cancer progression. Patients should consult their healthcare provider to determine if Vitrakvi is appropriate for their condition.

Side Effects

Vitrakvi works by targeting cancer cells with NTRK gene fusions, helping to slow or stop their growth. Patients may experience improved symptoms or disease stabilization during treatment. Regular monitoring by a healthcare professional is recommended to assess response and manage any changes in health.

Precautions & Warnings

Store Vitrakvi syrup refrigerated between 2–8°C and protect it from light. Keep the medication out of reach of children and pets. Do not use if the bottle seal is broken or the liquid appears discolored. Inform your doctor about all medications and health conditions before starting Vitrakvi.

Avoid Interactions

Vitrakvi may interact with strong CYP3A inhibitors or inducers, which can affect its levels in the body. Avoid grapefruit products while taking this medication, as they may alter its effectiveness. Discuss all prescription, over-the-counter, and herbal products with your healthcare provider to prevent potential interactions.

Frequently Asked Questions

Vitrakvi is used to treat solid tumors with an NTRK gene fusion in adults and children.

Store Vitrakvi syrup refrigerated between 2–8°C and protect it from light.

Inform your doctor about all medications you are taking, as Vitrakvi may interact with certain drugs.

No, Vitrakvi is a targeted therapy designed to block signals that drive cancer growth.

Patients with known allergies to larotrectinib or any ingredient in Vitrakvi should avoid this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.